Published in J Invest Dermatol on December 01, 2002
Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system. Adv Anat Embryol Cell Biol (2012) 2.99
Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr Rev (2008) 2.98
Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid (2014) 2.77
Key role of CRF in the skin stress response system. Endocr Rev (2013) 1.77
Neuroimmunology of stress: skin takes center stage. J Invest Dermatol (2006) 1.72
Sonic hedgehog-induced type 3 deiodinase blocks thyroid hormone action enhancing proliferation of normal and malignant keratinocytes. Proc Natl Acad Sci U S A (2007) 1.54
Preservation of eumelanin hair pigmentation in proopiomelanocortin-deficient mice on a nonagouti (a/a) genetic background. Endocrinology (2004) 1.45
Neuroendocrine system of the skin. Dermatology (2005) 1.24
Reawakened interest in type III iodothyronine deiodinase in critical illness and injury. Nat Clin Pract Endocrinol Metab (2008) 1.22
Local melatoninergic system as the protector of skin integrity. Int J Mol Sci (2014) 1.15
Neuroendocrine activity of the melanocyte. Exp Dermatol (2009) 1.12
On the role of skin in the regulation of local and systemic steroidogenic activities. Steroids (2015) 1.01
Thyroid hormone action on skin. Dermatoendocrinol (2011) 0.92
Modulation of the human hair follicle pigmentary unit by corticotropin-releasing hormone and urocortin peptides. FASEB J (2006) 0.90
The thyroid hormone receptors as modulators of skin proliferation and inflammation. J Biol Chem (2011) 0.88
Targeted skin overexpression of the mineralocorticoid receptor in mice causes epidermal atrophy, premature skin barrier formation, eye abnormalities, and alopecia. Am J Pathol (2007) 0.87
Possible link between Hashimoto's thyroiditis and oral lichen planus: a novel association found. Clin Oral Investig (2012) 0.86
Induction of sodium/iodide symporter (NIS) expression and radioiodine uptake in non-thyroid cancer cells. PLoS One (2012) 0.86
Modulation of the Akt/Ras/Raf/MEK/ERK pathway by A₃ adenosine receptor. Purinergic Signal (2006) 0.83
Hypothalamic-pituitary-thyroid axis hormones stimulate mitochondrial function and biogenesis in human hair follicles. J Invest Dermatol (2013) 0.82
Neuroendocrinology of the skin: An overview and selective analysis. Dermatoendocrinol (2011) 0.81
Biosynthesis of 3-iodothyronamine (T1AM) is dependent on the sodium-iodide symporter and thyroperoxidase but does not involve extrathyroidal metabolism of T4. Endocrinology (2012) 0.80
The thyroid hormone receptors modulate the skin response to retinoids. PLoS One (2011) 0.79
TSH-receptor-expressing fibrocytes and thyroid-associated ophthalmopathy. Nat Rev Endocrinol (2015) 0.78
Impaired hair growth and wound healing in mice lacking thyroid hormone receptors. PLoS One (2014) 0.78
An Intimate Relationship between Thyroid Hormone and Skin: Regulation of Gene Expression. Front Endocrinol (Lausanne) (2013) 0.76
Thyroid hormone and wound healing. J Thyroid Res (2013) 0.76
Thyroid hormone signaling controls hair follicle stem cell function. Mol Biol Cell (2015) 0.76
Neuro-immune-endocrine functions of the skin: an overview. Expert Rev Dermatol (2013) 0.76
Kaposi's Sarcoma-Associated Herpesvirus Subversion of the Anti-Inflammatory Response in Human Skin Cells Reveals Correlates of Latency and Disease Pathogenesis. J Skin Cancer (2014) 0.76
Melatonin, mitochondria, and the skin. Cell Mol Life Sci (2017) 0.75
Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev (2002) 5.15
Neuroendocrinology of the skin. Endocr Rev (2000) 3.34
Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev (2000) 2.98
Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure-function relationships. Physiol Rev (2002) 1.96
Elephantiasic pretibial myxedema: insight into and a hypothesis regarding the pathogenesis of the extrathyroidal manifestations of Graves' disease. Thyroid (2000) 1.87
Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. FASEB J (2001) 1.74
Alternative splicing of CRH-R1 receptors in human and mouse skin: identification of new variants and their differential expression. FASEB J (2001) 1.59
Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class II molecule. Proc Natl Acad Sci U S A (1996) 1.56
Activation of target-tissue immune-recognition molecules by double-stranded polynucleotides. Proc Natl Acad Sci U S A (1999) 1.48
Positive regulation of melanin pigmentation by two key substrates of the melanogenic pathway, L-tyrosine and L-dopa. J Cell Sci (1988) 1.30
Clinical review 74: Dermatological manifestations of endocrine disorders. J Clin Endocrinol Metab (1995) 1.14
Immunoglobulins from Graves' disease patients interact with different sites on TSH receptor/LH-CG receptor chimeras than either TSH or immunoglobulins from idiopathic myxedema patients. Biochem Biophys Res Commun (1991) 1.13
Clinical review 132: The sodium iodide symporter and its potential role in cancer therapy. J Clin Endocrinol Metab (2001) 1.11
Characterization of corticotropin-releasing hormone (CRH) in human skin. J Clin Endocrinol Metab (1998) 1.06
Different populations of melanocytes are present in hair follicles and epidermis. Pigment Cell Res (1996) 1.01
Thyroid-specific expression and cyclic adenosine 3',5'-monophosphate autoregulation of the thyrotropin receptor gene involves thyroid transcription factor-1. Mol Endocrinol (1994) 1.01
Modification of melanogenesis in cultured human melanoma cells. In Vitro Cell Dev Biol Anim (2000) 1.00
Identification of thyroid transcription factor-1 in C cells and parathyroid cells. Endocrinology (1998) 0.99
Thyroid transcription factor 1 is calcium modulated and coordinately regulates genes involved in calcium homeostasis in C cells. Mol Cell Biol (1998) 0.92
Regulation of thyrotropin receptor gene expression in rat FRTL-5 thyroid cells. Endocrinology (1992) 0.90
Human epidermal keratinocytes in culture convert thyroxine to 3,5,3'-triiodothyronine by type II iodothyronine deiodination: a novel endocrine function of the skin. J Clin Endocrinol Metab (1988) 0.88
Identification of two novel splicing variants of human type II iodothyronine deiodinase mRNA. Mol Cell Endocrinol (2001) 0.88
Hormonal modulation of major histocompatibility complex class I gene expression involves an enhancer A-binding complex consisting of Fra-2 and the p50 subunit of NF-kappa B. J Biol Chem (1995) 0.84
TSH receptor transcripts and TSH receptor-like immunoreactivity in orbital and pretibial fibroblasts of patients with Graves' ophthalmopathy and pretibial myxedema. Thyroid (1997) 0.84
Graves' disease: a host defense mechanism gone awry. Int Rev Immunol (2000) 0.83
Hypothesis: possible role for the melatonin receptor in vitiligo: discussion paper. J R Soc Med (1989) 0.83
The pituitary-skin connection in amphibians. Reciprocal regulation of melanotrope cells and dermal melanocytes. Ann N Y Acad Sci (1999) 0.80
Development effects of thyroid hormone: the role of deiodinases in regulatory control. Biochem Soc Trans (1999) 0.79
Cloning and sequencing of complete thyrotropin receptor transcripts in pretibial fibroblast culture cells. J Endocrinol Invest (1996) 0.78
Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev (2004) 5.89
Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid (2006) 3.03
American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid (2012) 2.71
High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines. Cancer Res (2003) 2.49
A novel pathway for sequential transformation of 7-dehydrocholesterol and expression of the P450scc system in mammalian skin. Eur J Biochem (2004) 2.42
Analysis of the H19ICR insulator. Mol Cell Biol (2007) 2.29
Radioactive iodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma. Clin Endocrinol (Oxf) (2013) 2.19
The cytochrome P450scc system opens an alternate pathway of vitamin D3 metabolism. FEBS J (2005) 2.12
Association of vascular invasion with increased mortality in patients with minimally invasive follicular thyroid carcinoma but not widely invasive follicular thyroid carcinoma. Head Neck (2014) 2.10
Unusual foreign bodies in the urinary bladder and urethra due to autoerotism. Int Neurourol J (2010) 1.95
Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer. BMC Med Genomics (2009) 1.91
Hair follicle pigmentation. J Invest Dermatol (2005) 1.84
Key role of CRF in the skin stress response system. Endocr Rev (2013) 1.77
The cutaneous serotoninergic/melatoninergic system: securing a place under the sun. FASEB J (2005) 1.77
An alternative pathway of vitamin D metabolism. Cytochrome P450scc (CYP11A1)-mediated conversion to 20-hydroxyvitamin D2 and 17,20-dihydroxyvitamin D2. FEBS J (2006) 1.75
Differential expression of HPA axis homolog in the skin. Mol Cell Endocrinol (2006) 1.72
Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization. J Nucl Med (2006) 1.72
Further exploring the brain-skin connection: stress worsens dermatitis via substance P-dependent neurogenic inflammation in mice. J Invest Dermatol (2007) 1.67
Regulation of human epidermal melanocyte biology by beta-endorphin. J Invest Dermatol (2003) 1.66
Extent of prophylactic lymph node dissection in the central neck area of the patients with papillary thyroid carcinoma: comparison of limited versus comprehensive lymph node dissection in a 2-year safety study. Ann Surg Oncol (2008) 1.66
NF-kappaB transmits Eda A1/EdaR signalling to activate Shh and cyclin D1 expression, and controls post-initiation hair placode down growth. Development (2006) 1.66
CRH stimulation of corticosteroids production in melanocytes is mediated by ACTH. Am J Physiol Endocrinol Metab (2004) 1.64
Elevated risks of subsequent primary malignancies in patients with thyroid cancer: a nationwide, population-based study in Korea. Cancer (2014) 1.60
Prevalence, clinical and ultrasonographic characteristics of thyroid incidentalomas. Thyroid (2004) 1.56
Differential expression of a cutaneous corticotropin-releasing hormone system. Endocrinology (2003) 1.46
Preservation of eumelanin hair pigmentation in proopiomelanocortin-deficient mice on a nonagouti (a/a) genetic background. Endocrinology (2004) 1.45
Corticotropin releasing hormone and the skin. Front Biosci (2006) 1.45
On the role of melatonin in skin physiology and pathology. Endocrine (2005) 1.43
CRH stimulates POMC activity and corticosterone production in dermal fibroblasts. J Neuroimmunol (2005) 1.42
A new small-molecule antagonist inhibits Graves' disease antibody activation of the TSH receptor. J Clin Endocrinol Metab (2010) 1.42
Laparoendoscopic single-site nephroureterectomy for upper urinary tract urothelial carcinoma: outcomes of an international multi-institutional study of 101 patients. BJU Int (2013) 1.42
Radiation safety: implications for urologists and patients. J Urol (2008) 1.42
Melanocortin receptor ligands: new horizons for skin biology and clinical dermatology. J Invest Dermatol (2006) 1.41
Functional activity of serotoninergic and melatoninergic systems expressed in the skin. J Cell Physiol (2003) 1.41
Recurrence after treatment of micropapillary thyroid cancer. Thyroid (2009) 1.41
Ultrasound in-depth characterization and staging of hidradenitis suppurativa. Dermatol Surg (2013) 1.40
Phenylmethimazole inhibits production of proinflammatory mediators and is protective in an experimental model of endotoxic shock*. Crit Care Med (2012) 1.39
Dilated cardiomyopathy in mice deficient for the lysosomal cysteine peptidase cathepsin L. Proc Natl Acad Sci U S A (2002) 1.37
Enzymatic metabolism of ergosterol by cytochrome p450scc to biologically active 17alpha,24-dihydroxyergosterol. Chem Biol (2005) 1.36
Serotoninergic and melatoninergic systems are fully expressed in human skin. FASEB J (2002) 1.33
Constitutive and UV-induced metabolism of melatonin in keratinocytes and cell-free systems. FASEB J (2006) 1.29
Migration of melanoblasts into the developing murine hair follicle is accompanied by transient c-Kit expression. J Histochem Cytochem (2002) 1.26
Antitumor effects of the proteasome inhibitor bortezomib in medullary and anaplastic thyroid carcinoma cells in vitro. J Clin Endocrinol Metab (2006) 1.24
The sunburn response in human skin is characterized by sequential eicosanoid profiles that may mediate its early and late phases. FASEB J (2009) 1.22
Cytochromes p450 and skin cancer: role of local endocrine pathways. Anticancer Agents Med Chem (2014) 1.20
Melatonin in the skin: synthesis, metabolism and functions. Trends Endocrinol Metab (2007) 1.20
Skin as an endocrine organ: implications for its function. Drug Discov Today Dis Mech (2008) 1.19
EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II study. Gastrointest Endosc (2012) 1.19
Ancient mitochondrial DNA from hair. Curr Biol (2004) 1.19
Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma. World J Surg (2013) 1.18
Regulated proenkephalin expression in human skin and cultured skin cells. J Invest Dermatol (2010) 1.17
Characterization of a ultraviolet B-induced corticotropin-releasing hormone-proopiomelanocortin system in human melanocytes. Mol Endocrinol (2006) 1.16
Diffuse sclerosing variant of papillary carcinoma of the thyroid: imaging and cytologic findings. Thyroid (2007) 1.14
BRAFV600E mutation analysis in fine-needle aspiration cytology specimens for evaluation of thyroid nodule: a large series in a BRAFV600E-prevalent population. J Clin Endocrinol Metab (2010) 1.13
Serotoninergic system in hamster skin. J Invest Dermatol (2002) 1.12
Prognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosis. Thyroid (2013) 1.12
Genome-wide nucleosome map and cytosine methylation levels of an ancient human genome. Genome Res (2013) 1.12
Mutant enrichment with 3'-modified oligonucleotides a practical PCR method for detecting trace mutant DNAs. J Mol Diagn (2011) 1.12
Proopiomelanocortin (POMC), the ACTH/melanocortin precursor, is secreted by human epidermal keratinocytes and melanocytes and stimulates melanogenesis. FASEB J (2007) 1.12
Clinical implication of highly sensitive detection of the BRAF V600E mutation in fine-needle aspirations of thyroid nodules: a comparative analysis of three molecular assays in 4585 consecutive cases in a BRAF V600E mutation-prevalent area. J Clin Endocrinol Metab (2012) 1.12
Activation of the Mitf promoter by lipid-stimulated activation of p38-stress signalling to CREB. Pigment Cell Res (2006) 1.10
Epigenetic silencing of the WNT antagonist DICKKOPF-1 in cervical cancer cell lines. Gynecol Oncol (2008) 1.09
Ultrasound accuracy in the diagnosis of skin and soft-tissue lesions. AJR Am J Roentgenol (2015) 1.09
Thyroglobulin: a specific serum marker for the management of thyroid carcinoma. Clin Lab Med (2004) 1.07
Essential role of the keratinocyte-specific endonuclease DNase1L2 in the removal of nuclear DNA from hair and nails. J Invest Dermatol (2011) 1.07
Allele-specific deposition of macroH2A1 in imprinting control regions. Hum Mol Genet (2006) 1.06
Clinical usefulness of variable-frequency ultrasound in localized lesions of the skin. J Am Acad Dermatol (2009) 1.05
Bilateral pheochromocytoma associated with paraganglioma and papillary thyroid carcinoma: report of an unusual case. Endocr J (2007) 1.05
Conversion of L-tryptophan to serotonin and melatonin in human melanoma cells. FEBS Lett (2002) 1.05
Hair cycle and hair pigmentation: dynamic interactions and changes associated with aging. Micron (2004) 1.04
Radioiodine therapy in patients with stage I differentiated thyroid cancer. Thyroid (2010) 1.04
Stress exposure modulates peptidergic innervation and degranulates mast cells in murine skin. Brain Behav Immun (2005) 1.04
Severe coronary artery spasm can be associated with hyperthyroidism. Coron Artery Dis (2005) 1.03
Phenylmethimazole decreases Toll-like receptor 3 and noncanonical Wnt5a expression in pancreatic cancer and melanoma together with tumor cell growth and migration. Clin Cancer Res (2009) 1.03
The mitochondrial electron transport chain is dispensable for proliferation and differentiation of epidermal progenitor cells. Stem Cells (2011) 1.03
Deregulation of DNA methyltransferases and loss of parental methylation at the insulin-like growth factor II (Igf2)/H19 loci in p53 knockout mice prior to tumor development. J Cell Biochem (2005) 1.03
Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer. Clin Endocrinol (Oxf) (2013) 1.02
Decreased health-related quality of life in disease-free survivors of differentiated thyroid cancer in Korea. Health Qual Life Outcomes (2010) 1.02
A case of resistance to thyroid hormone with thyroid cancer. J Korean Med Sci (2010) 1.01